Wire · opportunities
FDA Clears Roche cobas eplex RP3 Respiratory Test Panel
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 4 November 2026 · Fusion42 review
Roche received FDA 510(k) clearance for its cobas eplex RP3 respiratory test panel, which can detect up to 19 viral and bacterial pathogens including Bordetella pertussis in under two hours with customizable configurations to fit local needs.
This Wire brief sits within Fusion42's coverage of Diagnostics, and 3 sources have reported it between 2 Nov 2026 and 4 Nov 2026.
◆ ◆ The Wire takeaway
You have new FDA-approved tools to speed respiratory diagnostics in critical care. Act now to integrate automated, multi-pathogen testing that can cut antibiotic misuse and improve patient management.
◆ Coverage
3 sources · first reported 2 Nov 2026 · latest 4 Nov 2026
◆ Related on Wire
◆ Topics